Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]

Abstract

License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information… (More)
DOI: 10.2147/COPD.S82829

Topics

Statistics

05020162017
Citations per Year

Citation Velocity: 16

Averaging 16 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@inproceedings{Wang2015EfficacyAS, title={Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]}, author={Charles Wang and Tao Sun and Y. Huang}, booktitle={International journal of chronic obstructive pulmonary disease}, year={2015} }